True North Therapeutics, Inc.

A team that discovered and performed early development on Sanofi ’s recently approved rare disease drug Enjaymo (sutimlimab) has launched Star Therapeutics and its first portfolio company, Electra Th

Biopharmaceutical companies developing therapies for neurological diseases are in the midst of a boom, not only in terms of novel approaches to treating intractable diseases but also in terms of attra

Sanofi has suffered a surprising regulatory setback after being hit by a rejection from the US Food and Administration for sutimlimab, its treatment of hemolysis in adults with cold agglutinin diseas

John Milligan is to stand down as CEO of Gilead Sciences Inc. at the end of the year. Former CEO and current chair John Martin will also stand down upon the appointment of a new CEO. Milligan